Saurabh Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Saurabh Kumar has a total of 132 co-authors. Here are the top co-authors by number of shared publications:
Shama Parveen
Department of Zoology, Molecular and Human Genetics Laboratory, University of Lucknow, Lucknow 226007, Uttar Pradesh, India
20 shared publicationsMonisha Banerjee
Department of Zoology, Molecular and Human Genetics Laboratory, University of Lucknow, Lucknow 226007, Uttar Pradesh, India
19 shared publications- Monisha Banerjee
Molecular and Human Genetics Laboratory, Department of Zoology, University of Lucknow, Lucknow 226007, Uttar Pradesh, India
10 shared publications - Chandkiram Gautam
University of Lucknow
4 shared publications Pratishtha Gupta
Department of Zoology, Molecular and Human Genetics Laboratory, University of Lucknow, Lucknow 226007, Uttar Pradesh, India
4 shared publicationsRajat Kumar Mishra
Department of Physics, University of Lucknow, Lucknow, India
4 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1206
Plant-Derived Bioactive Compounds in Chronic Obstructive Pulmonary Disease: Targeting Oxidative Stress and Inflammatory Signaling
Chronic obstructive pulmonary disease (COPD) is characterised by persistent airflow limitation arising from chronic inflammation, oxidative stress, mucus hypersecretion, protease–antiprotease imbalance, airway remodelling, and emphysematous destruction. This review evaluates plant-derived bioactive compounds with reported activity against molecular processes implicated in COPD. Resveratrol, kaempferol, quercetin, fisetin, epigallocatechin gallate, gallic acid, ursolic acid, hesperidin, apigenin, and luteolin are examined with emphasis on Nrf2, NF-κB, MAPKs, PI3K/Akt, SIRT1, TLR4, and NLRP3 signalling. In selected cellular and animal models, these compounds have been reported to reduce oxidative stress, inflammatory mediator release, mucus production, metalloproteinase activity, and tissue injury. However, these experimental findings do not establish therapeutic efficacy in patients with COPD. Some also affect autophagy, corticosteroid sensitivity, and pathways associated with cellular senescence. Overall, the evidence is derived mainly from cultured cells and animal models, with limited clinical data. Poor oral bioavailability, rapid metabolism, uncertain pulmonary exposure, formulation variability, dose standardisation, and potential drug interactions remain major translational limitations. Future studies should define pharmacokinetics, lung tissue exposure, optimal formulations, safety, and interactions with standard COPD therapies, followed by adequately powered clinical trials assessing exacerbations, lung function, symptoms, exercise capacity, quality of life, and treatment-related adverse effects in well-defined COPD populations.
- 12 November 2026
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 48 (11) , 1206
Open AccessPlant-Derived Bioactive Compounds in Chronic Obstructive Pulmonary Disease: Targeting Oxidative Stress and Inflammatory Signaling
Chronic obstructive pulmonary disease (COPD) is characterised by persistent airflow limitation arising from chronic inflammation, oxidative stress, mucus hypersecretion, protease–antiprotease imbalance, airway remodelling, and emphysematous destruction. This review evaluates plant-derived bioactive compounds with reported activity against molecular processes implicated in COPD. Resveratrol, kaempferol, quercetin, fisetin, epigallocatechin gallate, gallic acid, ursolic acid, hesperidin, apigenin, and luteolin are examined with emphasis on Nrf2, NF-κB, MAPKs, PI3K/Akt, SIRT1, TLR4, and NLRP3 signalling. In selected cellular and animal models, these compounds have been reported to reduce oxidative stress, inflammatory mediator release, mucus production, metalloproteinase activity, and tissue injury. However, these experimental findings do not establish therapeutic efficacy in patients with COPD. Some also affect autophagy, corticosteroid sensitivity, and pathways associated with cellular senescence. Overall, the evidence is derived mainly from cultured cells and animal models, with limited clinical data. Poor oral bioavailability, rapid metabolism, uncertain pulmonary exposure, formulation variability, dose standardisation, and potential drug interactions remain major translational limitations. Future studies should define pharmacokinetics, lung tissue exposure, optimal formulations, safety, and interactions with standard COPD therapies, followed by adequately powered clinical trials assessing exacerbations, lung function, symptoms, exercise capacity, quality of life, and treatment-related adverse effects in well-defined COPD populations.
- Open Access
- 23 September 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (37) , e74570
Design, Synthesis and Biological Profiling of Fe(III)–Bipyridine Schiff Base Complexes: Experimental, Computational and Pharmacokinetic Insights
Schiff base ligands and their transition metal complexes continue to attract attention for their versatile coordination behavior and biological relevance. Herein, three thiosemicarbazone ligands (L1–L3) were synthesized from para‐nitrobenzaldehyde and substituted thiosemicarbazides and converted to their corresponding iron(III)–bipyridine complexes (FT1–FT3). The compounds were characterized by FT–IR, UV–vis, 1 H/ 1 3 C NMR, ESI–MS, EPR, molar conductivity, and elemental analysis. Spectroscopic data confirmed coordination through the azomethine nitrogen and thione sulfur, evidenced by shifts in characteristic bands and new Fe─N and Fe─S vibrations. DFT optimization revealed a distorted octahedral geometry and provided HOMO–LUMO gaps, global reactivity descriptors, and molecular electrostatic potential maps. Anticancer (SiHa), antimycobacterial, and antifungal assays showed that FT3 was the most active, giving 72.85% antifungal inhibition at 1000 ppm together with improved anticancer and antibacterial activity. Molecular docking against HPV‐18 E2 (PDB 1F9F) and CYP51 (PDB 1EA1) gave favorable binding energies that correlated with the experimental trends, FT3 forming the most stable interactions. ADME predictions indicated broadly acceptable, though preliminary, pharmacokinetic behavior. Overall, these iron(III) Schiff base complexes display promising multi‐target activity warranting further mechanistic and preclinical study.
- 23 September 2026
- Published by Wiley in ChemistrySelect
- Vol. 11 (37) , e74570
Open AccessDesign, Synthesis and Biological Profiling of Fe(III)–Bipyridine Schiff Base Complexes: Experimental, Computational and Pharmacokinetic Insights
Schiff base ligands and their transition metal complexes continue to attract attention for their versatile coordination behavior and biological relevance. Herein, three thiosemicarbazone ligands (L1–L3) were synthesized from para‐nitrobenzaldehyde and substituted thiosemicarbazides and converted to their corresponding iron(III)–bipyridine complexes (FT1–FT3). The compounds were characterized by FT–IR, UV–vis, 1 H/ 1 3 C NMR, ESI–MS, EPR, molar conductivity, and elemental analysis. Spectroscopic data confirmed coordination through the azomethine nitrogen and thione sulfur, evidenced by shifts in characteristic bands and new Fe─N and Fe─S vibrations. DFT optimization revealed a distorted octahedral geometry and provided HOMO–LUMO gaps, global reactivity descriptors, and molecular electrostatic potential maps. Anticancer (SiHa), antimycobacterial, and antifungal assays showed that FT3 was the most active, giving 72.85% antifungal inhibition at 1000 ppm together with improved anticancer and antibacterial activity. Molecular docking against HPV‐18 E2 (PDB 1F9F) and CYP51 (PDB 1EA1) gave favorable binding energies that correlated with the experimental trends, FT3 forming the most stable interactions. ADME predictions indicated broadly acceptable, though preliminary, pharmacokinetic behavior. Overall, these iron(III) Schiff base complexes display promising multi‐target activity warranting further mechanistic and preclinical study.
- Open Access
- 24 November 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 16 (11) , 112313
Attack cancer: Through autophagic modulations as suppressor or promoter
Organelle integrity and maintenance of protein homeostasis and purpose is essential for fundamental equilibrium and survivability. Autophagy is the primary process which regulates the distribution of different cell loads to lysosomes for destruction and reuse. Extensive research illustrates the protective functions of autophagy against various diseases. Though in cancer, noticeably contrasting functions of autophagy have been evaluated in the prohibition of preliminary tumor evolution vs the continuance and, anabolic and catabolic variations of well-established and invasive tumors. Autophagy possesses numerous roles in tumor microenvironment (TME) establishment and associated immune cells function which is addressed in recent studies. Autophagic machinery which is employed in different autophagy-related pathways contributes to metastatic diseases and are distinct from classical autophagy. Therapeutic strategies based on the inhibition or induction of autophagy and related processes has helped in the designing of efficient anticancer drugs. According to the review, we evaluate and decipher the various purposes of autophagy and its association with autophagy mechanisms in course of tumor development, invasion and progression. We summarize the latest findings involving the role of these activities including tumor cells and TME and define further breakthrough in therapy aiming at autophagic activities in cancer.
- 24 November 2025
- Published by Baishideng Publishing Group Inc. in World Journal of Clinical Oncology
- Vol. 16 (11) , 112313
Open AccessAttack cancer: Through autophagic modulations as suppressor or promoter
Organelle integrity and maintenance of protein homeostasis and purpose is essential for fundamental equilibrium and survivability. Autophagy is the primary process which regulates the distribution of different cell loads to lysosomes for destruction and reuse. Extensive research illustrates the protective functions of autophagy against various diseases. Though in cancer, noticeably contrasting functions of autophagy have been evaluated in the prohibition of preliminary tumor evolution vs the continuance and, anabolic and catabolic variations of well-established and invasive tumors. Autophagy possesses numerous roles in tumor microenvironment (TME) establishment and associated immune cells function which is addressed in recent studies. Autophagic machinery which is employed in different autophagy-related pathways contributes to metastatic diseases and are distinct from classical autophagy. Therapeutic strategies based on the inhibition or induction of autophagy and related processes has helped in the designing of efficient anticancer drugs. According to the review, we evaluate and decipher the various purposes of autophagy and its association with autophagy mechanisms in course of tumor development, invasion and progression. We summarize the latest findings involving the role of these activities including tumor cells and TME and define further breakthrough in therapy aiming at autophagic activities in cancer.
- 16 November 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1353
Rutin as a multi-target anticancer agent: Molecular docking, ADMET, and in vitro efficacy against cervical cancer
- 16 November 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1353
Rutin as a multi-target anticancer agent: Molecular docking, ADMET, and in vitro efficacy against cervical cancer
- Open Access
- 23 April 2025
- Published by Elsevier in Toxicology Reports
- Vol. 14, 102031
Piperlongumine mediated apoptosis in cervical cancer cells beyond docking predictions
- 23 April 2025
- Published by Elsevier in Toxicology Reports
- Vol. 14, 102031
Open AccessPiperlongumine mediated apoptosis in cervical cancer cells beyond docking predictions
- 10 April 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1339
Novel Schiff base derivatives of curcumin, a blueprint to enhance its biological performance and its corroboration via in-vitro investigation against Siha cells in cervical cancer, in-silico approach and antifungal activity against Fusarium solani
- 10 April 2025
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1339
Novel Schiff base derivatives of curcumin, a blueprint to enhance its biological performance and its corroboration via in-vitro investigation against Siha cells in cervical cancer, in-silico approach and antifungal activity against Fusarium solani
- 22 May 2024
- Published by Springer Nature in Journal of Inorganic and Organometallic Polymers and Materials
- Vol. 34 (10) , 4763-4779
Optimized Performance of PMMA Denture Base Material: Enhanced Mechanical, Biocompatibility, and Antibacterial Properties Modified with Extracted Jackfruit Latex Resin (Artocarpus Heterophyllus)
- 22 May 2024
- Published by Springer Nature in Journal of Inorganic and Organometallic Polymers and Materials
- Vol. 34 (10) , 4763-4779
Optimized Performance of PMMA Denture Base Material: Enhanced Mechanical, Biocompatibility, and Antibacterial Properties Modified with Extracted Jackfruit Latex Resin (Artocarpus Heterophyllus)
- 28 January 2024
- Published by Elsevier in Ceramics International
- Vol. 50 (9) , 14550-14570
Fabrication of bioactive transparent glass ceramics 55SiO2–25Na2O-(15-x)CaO–5P2O5- xZrO2 (0≤x≤6): Physical, structural and in vitro cell viability insights for biomedical applications
- 28 January 2024
- Published by Elsevier in Ceramics International
- Vol. 50 (9) , 14550-14570
Fabrication of bioactive transparent glass ceramics 55SiO2–25Na2O-(15-x)CaO–5P2O5- xZrO2 (0≤x≤6): Physical, structural and in vitro cell viability insights for biomedical applications